Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) studyAntonia Zhu, Davinder S. Jassal, Ishika Mittal et al.|Canadian Journal of Physiology and Pharmacology|2020Cited by 4
SCLERAXIS AS A PROGNOSTIC MARKER OF MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY (SPARC) STUDYAntonia Zhu, Davinder S. Jassal, Hilary Bews et al.|Canadian Journal of Cardiology|2019Cited by 0